Cargando…

Selection of hepatitis C virus resistant to ribavirin

BACKGROUND: Given the side effects associated with intravenous injections of interferon, an interferon-free regimen for the treatment of HCV infections is highly desirable. Recently published clinical studies show that interferon-free combination therapies containing ribavirin are efficacious, sugge...

Descripción completa

Detalles Bibliográficos
Autores principales: Feigelstock, Dino A, Mihalik, Kathleen B, Feinstone, Stephen M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163560/
https://www.ncbi.nlm.nih.gov/pubmed/21843317
http://dx.doi.org/10.1186/1743-422X-8-402
_version_ 1782210961557422080
author Feigelstock, Dino A
Mihalik, Kathleen B
Feinstone, Stephen M
author_facet Feigelstock, Dino A
Mihalik, Kathleen B
Feinstone, Stephen M
author_sort Feigelstock, Dino A
collection PubMed
description BACKGROUND: Given the side effects associated with intravenous injections of interferon, an interferon-free regimen for the treatment of HCV infections is highly desirable. Recently published clinical studies show that interferon-free combination therapies containing ribavirin are efficacious, suggesting that an interferon-free therapy could be adopted in the near future. Therefore, understanding HCV resistance to ribavirin could be of major importance. In an approach to understand the effect of ribavirin on HCV replication and HCV resistance, we have selected a ribavirin resistant mutant of HCV in vitro. METHODS: We serially passed the J6/JFH1 strain of HCV in Huh7D cells (a Huh7 cell derivative more permissive to HCV replication) in the presence of different concentrations of ribavirin. Virus replication was assessed by detection of HCV antigens by immunfluorscence of infected cells and titration of recovered virus present in the supernatant. cDNAs from virus RNA grown in 0 or 250 uM concentrations of ribavirin were synthesized by RT-PCR, and sequenced. RESULTS: A concentration of 125 uM of ribavirin did not have a dramatic effect on HCV replication, while 500 uM of ribavirin lead to viral extinction. Concentrations of 250 uM of ribavirin dramatically reduced virus replication which was sustained over six passages. At passage seven viral resurgence began and over two passages the level of virus reached that of the wild type virus grown without ribavirin. Virus recovered from these cultures were more resistant to 250 uM ribavirin than wild type virus, and showed no difference in replication relative to wild type virus when grown in the absence of ribavirin. The ribavirin resistant virus accumulated multiple synonymous and non-synonymous mutations that are presently being analyzed for their relationship to ribavirin resistance. CONCLUSIONS: It is possible to select a ribavirin resistant mutant of HCV that can replicate to levels similar to wild type virus grown without ribavirin. Analysis of the mutations responsible for the ribavirin resistance may aid in understanding the mechanism of action of ribavirin.
format Online
Article
Text
id pubmed-3163560
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31635602011-08-30 Selection of hepatitis C virus resistant to ribavirin Feigelstock, Dino A Mihalik, Kathleen B Feinstone, Stephen M Virol J Research BACKGROUND: Given the side effects associated with intravenous injections of interferon, an interferon-free regimen for the treatment of HCV infections is highly desirable. Recently published clinical studies show that interferon-free combination therapies containing ribavirin are efficacious, suggesting that an interferon-free therapy could be adopted in the near future. Therefore, understanding HCV resistance to ribavirin could be of major importance. In an approach to understand the effect of ribavirin on HCV replication and HCV resistance, we have selected a ribavirin resistant mutant of HCV in vitro. METHODS: We serially passed the J6/JFH1 strain of HCV in Huh7D cells (a Huh7 cell derivative more permissive to HCV replication) in the presence of different concentrations of ribavirin. Virus replication was assessed by detection of HCV antigens by immunfluorscence of infected cells and titration of recovered virus present in the supernatant. cDNAs from virus RNA grown in 0 or 250 uM concentrations of ribavirin were synthesized by RT-PCR, and sequenced. RESULTS: A concentration of 125 uM of ribavirin did not have a dramatic effect on HCV replication, while 500 uM of ribavirin lead to viral extinction. Concentrations of 250 uM of ribavirin dramatically reduced virus replication which was sustained over six passages. At passage seven viral resurgence began and over two passages the level of virus reached that of the wild type virus grown without ribavirin. Virus recovered from these cultures were more resistant to 250 uM ribavirin than wild type virus, and showed no difference in replication relative to wild type virus when grown in the absence of ribavirin. The ribavirin resistant virus accumulated multiple synonymous and non-synonymous mutations that are presently being analyzed for their relationship to ribavirin resistance. CONCLUSIONS: It is possible to select a ribavirin resistant mutant of HCV that can replicate to levels similar to wild type virus grown without ribavirin. Analysis of the mutations responsible for the ribavirin resistance may aid in understanding the mechanism of action of ribavirin. BioMed Central 2011-08-15 /pmc/articles/PMC3163560/ /pubmed/21843317 http://dx.doi.org/10.1186/1743-422X-8-402 Text en Copyright ©2011 Feigelstock et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Feigelstock, Dino A
Mihalik, Kathleen B
Feinstone, Stephen M
Selection of hepatitis C virus resistant to ribavirin
title Selection of hepatitis C virus resistant to ribavirin
title_full Selection of hepatitis C virus resistant to ribavirin
title_fullStr Selection of hepatitis C virus resistant to ribavirin
title_full_unstemmed Selection of hepatitis C virus resistant to ribavirin
title_short Selection of hepatitis C virus resistant to ribavirin
title_sort selection of hepatitis c virus resistant to ribavirin
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163560/
https://www.ncbi.nlm.nih.gov/pubmed/21843317
http://dx.doi.org/10.1186/1743-422X-8-402
work_keys_str_mv AT feigelstockdinoa selectionofhepatitiscvirusresistanttoribavirin
AT mihalikkathleenb selectionofhepatitiscvirusresistanttoribavirin
AT feinstonestephenm selectionofhepatitiscvirusresistanttoribavirin